The content on this site is intended for healthcare professionals only
Treatment strategies involve multiple stages and management of complications. A benchmark trial reveals significant overall survival benefits and improved progression-free survival. Long-term data shows a seven-year survival advantage with manageable complications. Post-transplant therapy achieves high response rates and sustainable outcomes. Brentuximab is effective in first-line, second-line, and post-transplant settings, enhancing overall survival while reducing side effects.
Cancer in emergencies: What can we do better to protect the most vulnerable?
Tele-mentoring: Impact of project ECHO
Addressing the rise of multiple myeloma in Rwanda
Gastro-intestinal endoscopy capacity in Nigeria: strengths and challenges
Colorectal cancer risk factors in Nigeria
Synthetic biology and precision medicine in blood and gynaecological cancers
Supporting breast cancer patients in Vietnam
Neo-adjuvant therapy for different cancers in the Philippines
Lung cancer screening and treatment in the Philippines
